Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of therapeutic proteins and antibodies that modulate the activity of G protein-coupled receptors (GPCR). It develops a proprietary technology platform called GEODe to enable the discovery and development of GPCR-targeted biologic medicines. The company was founded by Timothy A. Springer and Andrew Kruse in November 2015 and is headquartered in Watertown, MA.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
60
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Tectonic Therapeutic Inc. market cap is $400.56M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tectonic Therapeutic Inc. 52 week high is $39.53 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tectonic Therapeutic Inc. 52 week low is $16.77 as of November 18, 2026.
Tectonic Therapeutic Inc. stock price today is $20.99.
Tectonic Therapeutic Inc. stock price yesterday was $20.08.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Tectonic Therapeutic Inc.'s P/E ratio is -4.34.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Tectonic Therapeutic Inc. P/B ratio is 1.7255.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Tectonic Therapeutic Inc. 50-day moving average is $22.90.